Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes.
Novel chemical controls are needed that selectively target human, animal, and plant parasitic nematodes with reduced adverse effects on the host or the environment. We hypothesize that the phosphodiesterase (PDE) enzyme family represents a potential target for development of novel nematicides and an...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0214554 |
| _version_ | 1818584178055184384 |
|---|---|
| author | Kevin D Schuster Mohammadjavad Mohammadi Karyn B Cahill Suzanne L Matte Alexis D Maillet Harish Vashisth Rick H Cote |
| author_facet | Kevin D Schuster Mohammadjavad Mohammadi Karyn B Cahill Suzanne L Matte Alexis D Maillet Harish Vashisth Rick H Cote |
| author_sort | Kevin D Schuster |
| collection | DOAJ |
| description | Novel chemical controls are needed that selectively target human, animal, and plant parasitic nematodes with reduced adverse effects on the host or the environment. We hypothesize that the phosphodiesterase (PDE) enzyme family represents a potential target for development of novel nematicides and anthelmintics. To test this, we identified six PDE families present in the nematode phylum that are orthologous to six of the eleven human PDE families. We characterized the binding interactions of family-selective PDE inhibitors with human and C. elegans PDE4 in conjunction with molecular dynamics (MD) simulations to evaluate differences in binding interactions of these inhibitors within the PDE4 catalytic domain. We observed that roflumilast (human PDE4-selective inhibitor) and zardaverine (selective for human PDE3 and PDE4) were 159- and 77-fold less potent, respectively, in inhibiting C. elegans PDE4. The pan-specific PDE inhibitor isobutyl methyl xanthine (IBMX) had similar affinity for nematode and human PDE4. Of 32 residues within 5 Å of the ligand binding site, five revealed significant differences in non-bonded interaction energies (van der Waals and electrostatic interaction energies) that could account for the differential binding affinities of roflumilast and zardaverine. One site (Phe506 in the human PDE4D3 amino acid sequence corresponding to Tyr253 in C. elegans PDE4) is predicted to alter the binding conformation of roflumilast and zardaverine (but not IBMX) into a less energetically favorable state for the nematode enzyme. The pharmacological differences in sensitivity to PDE4 inhibitors in conjunction with differences in the amino acids comprising the inhibitor binding sites of human and C. elegans PDE4 catalytic domains together support the feasibility of designing the next generation of anthelmintics/nematicides that could selectively bind to nematode PDEs. |
| first_indexed | 2024-12-16T08:17:02Z |
| format | Article |
| id | doaj.art-87194c07a26f4842992eb1be6c0087df |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-16T08:17:02Z |
| publishDate | 2019-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-87194c07a26f4842992eb1be6c0087df2022-12-21T22:38:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01143e021455410.1371/journal.pone.0214554Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes.Kevin D SchusterMohammadjavad MohammadiKaryn B CahillSuzanne L MatteAlexis D MailletHarish VashisthRick H CoteNovel chemical controls are needed that selectively target human, animal, and plant parasitic nematodes with reduced adverse effects on the host or the environment. We hypothesize that the phosphodiesterase (PDE) enzyme family represents a potential target for development of novel nematicides and anthelmintics. To test this, we identified six PDE families present in the nematode phylum that are orthologous to six of the eleven human PDE families. We characterized the binding interactions of family-selective PDE inhibitors with human and C. elegans PDE4 in conjunction with molecular dynamics (MD) simulations to evaluate differences in binding interactions of these inhibitors within the PDE4 catalytic domain. We observed that roflumilast (human PDE4-selective inhibitor) and zardaverine (selective for human PDE3 and PDE4) were 159- and 77-fold less potent, respectively, in inhibiting C. elegans PDE4. The pan-specific PDE inhibitor isobutyl methyl xanthine (IBMX) had similar affinity for nematode and human PDE4. Of 32 residues within 5 Å of the ligand binding site, five revealed significant differences in non-bonded interaction energies (van der Waals and electrostatic interaction energies) that could account for the differential binding affinities of roflumilast and zardaverine. One site (Phe506 in the human PDE4D3 amino acid sequence corresponding to Tyr253 in C. elegans PDE4) is predicted to alter the binding conformation of roflumilast and zardaverine (but not IBMX) into a less energetically favorable state for the nematode enzyme. The pharmacological differences in sensitivity to PDE4 inhibitors in conjunction with differences in the amino acids comprising the inhibitor binding sites of human and C. elegans PDE4 catalytic domains together support the feasibility of designing the next generation of anthelmintics/nematicides that could selectively bind to nematode PDEs.https://doi.org/10.1371/journal.pone.0214554 |
| spellingShingle | Kevin D Schuster Mohammadjavad Mohammadi Karyn B Cahill Suzanne L Matte Alexis D Maillet Harish Vashisth Rick H Cote Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes. PLoS ONE |
| title | Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes. |
| title_full | Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes. |
| title_fullStr | Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes. |
| title_full_unstemmed | Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes. |
| title_short | Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes. |
| title_sort | pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode pde4 implications for management of parasitic nematodes |
| url | https://doi.org/10.1371/journal.pone.0214554 |
| work_keys_str_mv | AT kevindschuster pharmacologicalandmoleculardynamicsanalysesofdifferencesininhibitorbindingtohumanandnematodepde4implicationsformanagementofparasiticnematodes AT mohammadjavadmohammadi pharmacologicalandmoleculardynamicsanalysesofdifferencesininhibitorbindingtohumanandnematodepde4implicationsformanagementofparasiticnematodes AT karynbcahill pharmacologicalandmoleculardynamicsanalysesofdifferencesininhibitorbindingtohumanandnematodepde4implicationsformanagementofparasiticnematodes AT suzannelmatte pharmacologicalandmoleculardynamicsanalysesofdifferencesininhibitorbindingtohumanandnematodepde4implicationsformanagementofparasiticnematodes AT alexisdmaillet pharmacologicalandmoleculardynamicsanalysesofdifferencesininhibitorbindingtohumanandnematodepde4implicationsformanagementofparasiticnematodes AT harishvashisth pharmacologicalandmoleculardynamicsanalysesofdifferencesininhibitorbindingtohumanandnematodepde4implicationsformanagementofparasiticnematodes AT rickhcote pharmacologicalandmoleculardynamicsanalysesofdifferencesininhibitorbindingtohumanandnematodepde4implicationsformanagementofparasiticnematodes |